Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetramethylammonium Ion SCHEMBL23909442 | 1.00 | LMNA (0.36) | LMNACA1CA2MMP1MMP2 | |
| Tetramethylammonium Ion SCHEMBL21062100 | 0.97 | LMNA (0.32) | LMNA | |
| Tetramethylammonium Ion SCHEMBL15873984 | 0.88 | — | — | |
| SCHEMBL28889669 | 0.84 | LMNA (0.42) | LMNACA1CA2MMP1MMP2 | |
| Potassium Ion SCHEMBL8010764 | 0.81 | LMNA (0.37) | LMNACA1CA2MMP1MMP2 | |
| Hydrogen Sulfide SCHEMBL28468639 | 0.73 | LMNA (0.57) | LMNACA1CA2MMP1MMP2 | |
| Hydrogen Sulfide SCHEMBL27514193 | 0.73 | LMNA (0.57) | LMNACA1CA2MMP1MMP2 | |
| Hydrogen Sulfide SCHEMBL28956837 | 0.73 | LMNA (0.57) | LMNACA1CA2MMP1MMP2 | |
| Lithium Ion SCHEMBL11661857 | 0.70 | LMNA (0.32) | LMNA | |
| Potassium Ion SCHEMBL10969351 | 0.70 | LMNA (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317061-A1 | METHOD FOR PRODUCING FLUOROALKOXIDE | DAIKIN INDUSTRIES, LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317061-A1 | METHOD FOR PRODUCING FLUOROALKOXIDE | CBR3, AKR7A2, CBR1 | LMNA 4412/4885CA1 3692/4885CA2 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.